Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow Reinvestment Rate
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Reinvestment Rate of 0.51x as of September 2025, reinvesting CN¥1.81 Million (capex CN¥1.81 Million ) from operating cash flow of CN¥3.56 Million. See 688488 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. For the full cash flow conversion analysis, see Jiangsu Aidea Pharmaceutical Co Ltd (688488) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Jiangsu Aidea Pharmaceutical Co Ltd. See financial flexibility index of Jiangsu Aidea Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.93x | CN¥51.67 Million | CN¥17.63 Million | CN¥47.93 Million | ▼ -71.5% |
| 2020 | 10.28x | CN¥577.43 Million | CN¥56.17 Million | CN¥42.43 Million | ▲ +1439.1% |
| 2019 | 0.67x | CN¥37.54 Million | CN¥56.20 Million | CN¥33.50 Million | ▼ -70.6% |
| 2016 | 2.27x | CN¥71.01 Million | CN¥31.29 Million | CN¥71.01 Million | — |